Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Withdrawn × Levobupivacaine × Clear all

Phase

Phase NA 1 Phase 4 1

Status

Completed 2 Withdrawn 1 Terminated 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Bites and Stings 1

Interventions

Metformin 3 Letrozole 3 Sperm Injections, Intracytoplasmic 2 Progesterone 2 Lidocaine 2 Indocyanine Green 2 Gentamicins 2 Estradiol 2 Clomiphene 2 Bevacizumab 2 tirbanibulin 1 technetium Tc 99m nanocolloid 1 suvorexant 1 pomalidomide 1 pembrolizumab 1 pasireotide 1 nilotinib 1 methylnaltrexone 1 ledipasvir 1 ixazomib 1 gadolinium ethoxybenzyl DTPA 1 gadofosveset trisodium 1 exemestane 1 dolutegravir 1 ceftolozane, tazobactam drug combination 1 apatinib 1 abemaciclib 1 Zoledronic Acid 1 Vortioxetine 1 Venlafaxine Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02121951 2018-04-10

QLB

National Cancer Institute, Egypt

Phase 4 Withdrawn

Bites and Stings, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡